3 Healthcare Stock Stories For Monday Investment Wellness
Biogen IDEC (NASDAQ: BIIB): Closing price $222.74 On Monday Biogen said that the FDA has accepted its Biologics License Application for the marketing approval of Eloctate (recombinant factor VIII Fc...
View Article3 Healthcare Stock Stories To End the Trading Week
Novartis (NYSE:NVS): Closing price $70.72 The Novartis drug Lucentis has been approved in the European Union as the first effective anti-VEGF treatment for myopic choroidal neovascularization. Lucentis...
View Article4 Healthcare Stock Stories Making Tracks on Monday
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS): Closing price $31.81 On Monday, Biogen IDEC and Isis announced that they will work jointly to leverage antisense tech in the advancement of the treatment of...
View Article
More Pages to Explore .....